Cargando…
Determining Levers of Cost-effectiveness for Screening Infants at High Risk for Peanut Sensitization Before Early Peanut Introduction
IMPORTANCE: Early peanut introduction reduces the risk of developing peanut allergy, especially in high-risk infants. Current US recommendations endorse screening but are not cost-effective relative to other international strategies. OBJECTIVE: To identify scenarios in which current early peanut int...
Autores principales: | Greenhawt, Matthew, Shaker, Marcus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991237/ https://www.ncbi.nlm.nih.gov/pubmed/31860109 http://dx.doi.org/10.1001/jamanetworkopen.2019.18041 |
Ejemplares similares
-
Estimation of Health and Economic Benefits of Commercial Peanut Immunotherapy Products: A Cost-effectiveness Analysis
por: Shaker, Marcus, et al.
Publicado: (2019) -
Association of Fatality Risk With Value-Based Drug Pricing of Epinephrine Autoinjectors for Children With Peanut Allergy: A Cost-effectiveness Analysis
por: Shaker, Marcus, et al.
Publicado: (2018) -
Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants
por: Fleischer, David M., et al.
Publicado: (2015) -
Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants
por: Fleischer, David M., et al.
Publicado: (2015) -
Genotypic Characterization of the U.S. Peanut Core Collection
por: Otyama, Paul I., et al.
Publicado: (2020)